Showing results (81-90 of 150) with videos related to
Sort By:
Pageof 15
Current Medicinal Chemistry|March 11, 2014
Non-steroidal anti-inflammatory drugs (NSAIDs) in the management of patent ductus arteriosus (PDA) in preterm infants and variations in attitude in clinical practice: a flight around the worldR Irmesi, M A Marcialis, J van den Anker, et al.Developmental Pharmacology and Therapeutics|January 1, 1993
Pharmacokinetics of amikacin in neonatesE M Padovani, C Pistolesi, V Fanos, et al.Journal of Developmental Origins of Health and Disease|June 4, 2016
Epicardial fat thickness, an emerging cardiometabolic risk factor, is increased in young adults born pretermP P Bassareo, V Fanos, M Puddu, et al.La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics|July 1, 1997
[Glycopeptides and the newborn infant's kidney]V Fanos, D Benini, S Vinco, et al.La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics|May 21, 1999
[Renal calculosis in pediatrics]B J Khoory, A Pedrolli, S Vecchini, et al.Pediatric Nephrology (Berlin, Germany)|October 1, 1996
Evaluation of antibiotic-induced nephrotoxicity in preterm neonates by determining urinary alpha 1-microglobulinV Fanos, M Mussap, G Verlato, et al.Minerva Pediatrica|June 5, 1999
[Hematuria in pediatric clinical practice]B J Khoory, D Benini, A Pedrolli, et al.Antimicrobial Agents and Chemotherapy|September 1, 1991
Pharmacokinetics and renal tolerance of aztreonam in premature infantsL Cuzzolin, V Fanos, D Zambreri, et al.Italian Journal of Pediatrics|October 17, 2015
Each niche has an actor: multiple stem cell niches in the preterm kidneyD Fanni, A Sanna, C Gerosa, et al.Seminars in Fetal & Neonatal Medicine|December 1, 2012
Metabolomics in neonatology: fact or fiction?V Fanos, J Van den Anker, A Noto, et al.Pageof 15